SGRY Stock Recent News
SGRY LATEST HEADLINES
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire another company.
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire another company.
Surgery Partners (SGRY) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.28 per share a year ago.
BRENTWOOD, Tenn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2024.
Investors looking for stocks in the Medical Services sector might want to consider either Surgery Partners (SGRY) or Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
BRENTWOOD, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2024 results before the market opens on Tuesday, August 6, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time)
The mean of analysts' price targets for Surgery Partners (SGRY) points to a 57.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CHICAGO--(BUSINESS WIRE)--Oral Surgery Partners (“OSP”) announced today the closing of a $75 million credit expansion. The facility expansion was provided by the existing lending partners and will allow OSP to continue to grow through 2024 and beyond. “OSP's lenders continue to show strong support for the company due to its well-established track record and continued performance. We're excited to have like-minded lending partners who share the vision of providing excellent care in oral surgery.
Surgery Partners, Inc. (NASDAQ:SGRY ) Q1 2024 Results Conference Call May 4, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Brian Tanquilut - Jefferies Whit Mayo - SVB Leerink Kevin Fischbeck - Bank of America Andrew Mok - Barclays Sarah James - Cantor Fitzgerald Gary Taylor - TD Cowen Bill Sutherland - The Benchmark Company Jason Cassorla - Citi Cal Sternick - JPMorgan Chase Ben Hendrix - RBC Capital Markets Operator Greetings. Welcome to Surgery Partners First Quarter 2024 Earnings Call.
Surgery Partners (SGRY) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.08 per share a year ago.